Status:

UNKNOWN

The Follow-up Study for the Patients of Illicit Substance Use Disorder

Lead Sponsor:

Kaohsiung Kai-Suan Psychiatric Hospital

Collaborating Sponsors:

Kaohsiung Medical University

Chang Gung Memorial Hospital

Conditions:

Substance Use Disorders

Illicit Drug Use

Eligibility:

All Genders

20-65 years

Phase:

NA

Brief Summary

The patients will be diagnosed according to DSM-5, the severity of individual substance use disorder will be assessed, and the plan of treatment will be provided. The treatment will be determined by t...

Detailed Description

The patients will be diagnosed according to DSM-5, the severity of individual addiction will be assessed, and the plan of treatment will be provided. The treatment will be determined by the diagnosis ...

Eligibility Criteria

Inclusion

  • Patients with illicit substance use disorder diagnosed by DSM-5

Exclusion

  • The age of the patient is below 20 years old or above 65 years old, the patients cannot cooperate with the tools of investigation

Key Trial Info

Start Date :

May 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 30 2022

Estimated Enrollment :

500 Patients enrolled

Trial Details

Trial ID

NCT04426565

Start Date

May 1 2020

End Date

September 30 2022

Last Update

June 11 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Kaohsiung Municipal Kai-Syuan Psychiatric Hospital

Kaohsiung City, Taiwan, 886